Author:
Franklin Zara J.,Lafferty Ryan A.,Flatt Peter R.,McShane Laura M.,O'Harte Finbarr P.M.,Irwin Nigel
Subject
General Medicine,Biochemistry
Reference56 articles.
1. Effects of a novel glucagon receptor antagonist (Bay 27–9955) on glucagon-stimulated glucose production in humans;Petersen;Diabetologia,2001
2. The glucagon receptor is involved in mediating the body weight-lowering effects of oxyntomodulin;Kosinski;Obesity,2012
3. Oxyntomodulin analogue increases energy expenditure via the glucagon receptor;Scott;Peptides,2018
4. IBI362 (LY3305677), a weekly-dose GLP-1 and glucagon receptor dual agonist, in Chinese adults with overweight or obesity: a randomised, placebo-controlled, multiple ascending dose phase 1b study;Ji;EClin. Med.,2021
5. Proglucagon-derived peptides as therapeutics;Lafferty;Front. Endocrinol.,2021
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献